Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canned & Tomato Products

Canned & Tomato Products

Trevena's Play Out Of Pain Space Fails In Phase IIb

Trevena Inc.'s future as more than just a one-trick pony is in question following the company's announcement it is discontinuing development of acute heart failure therapy, TRV027, after the drug failed to meet primary or secondary endpoints in a Phase IIb study.

Clinical Trials Business Strategies Companies

NewLink’s HyperAcute Program In Limbo After Pancreatic Trial Blow-Up

Company says it is evaluating what to do with its HyperAcute vaccine candidates in various tumor types, as focus shifts toward IDO programs.

Clinical Trials Research and Development Strategies Cancer
Advertisement
UsernamePublicRestriction

Register